TPM1 and osteoporosis: Osteocyte-derived extracellular vesicles (YO-EVs) enriched with tropomyosin-1 (TPM1) enhance matrix stiffness and osteogenesis, highlighting their therapeutic potential for senile osteoporosis [146].